NTT Research Hosts UPGRADE 2020, Virtual Global Research Summit

 Adivision of NTT (TYO:9432), today announced plans to hold UPGRADE 2020 NTT Global Research Summit as a virtual event on September 28 - October 1. The online event, to be held 1:30-4:30 pm PST on each of these four days, will feature talks involving cryptography and blockchain, quantum information systems, and healthcare AI and biosensors. NTT Group President and CEO, Jun Sawada, and NTT Executive Vice President and Head of Research and Development Planning, Katsuhiko Kawazoe, will deliver opening remarks on Day 1, which will center on the theme of “Fundamental Research: A Foundation of a Better Future.” The subsequent three days will consist of breakout sessions featuring scientists from the three NTT Research Labs and various research partners.

Keynoting the event on September 28 will be two prominent academics in the fields of computer science and medical research, respectively: Professor Shafi Goldwasser and Dr. Peter J. Fitzgerald. Director of the computer science major jobs Institute for the Theory of Computing, Dr. Goldwasser is also a professor of computer science at UC Berkeley, the RSA Professor of Electrical Engineering and Computer Science at MIT, and a professor of computer science and applied mathematics at the Weizmann Institute of Science in Israel. She was the recipient of the Association for Computing Machinery (ACM) Alan Mathison (A.M.) Turing Award in 2012, along with Silvio Micali, for transformative work that laid the complexity-theoretic foundations for the science of cryptography and has received numerous other academic honors. Dr. Fitzgerald, M.D., Ph.D., is an interventional cardiologist with a doctorate in biomedical engineering, who also directs the Center for Cardiovascular Technology at Stanford University and the Cardiovascular Core Analysis Laboratory at Stanford University Medical School. Dr. Fitzgerald is a professor in the departments of medicine and engineering at Stanford, has led or participated in more than 100 clinical trials, published over 350 articles and chapters in medical journals and textbooks and been the principal or founder in more than a dozen medical device companies.